Orion Struggles To Make Headway With Rival To Seretide
You may also be interested in...
Amid declining sales of drugs covered by reference prices in Finland, local leader Orion says it has been able to slightly strengthen its market position.
Expanding sales from its Easyhaler line of respiratory devices alleviated pressure on Orion in the first quarter of 2019 as the Finnish group found most of its key product franchises under pressure.
Germany’s off-patent industry association, Pro Generika, is finding ample support for its position that by awarding tender contracts to exclusive suppliers, health insurance funds are contributing to drug shortages in the country.